Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates
Pediatrix Medical Group reported Q3 2026 earnings of $0.72 per share, beating consensus estimates of $0.63 and surpassing revenue expectations. The company has outperformed the S&P 500 by 35.2% year-to-date. However, it received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, with the Medical Services industry ranking in the bottom 40% of sectors.